CTOs on the Move

Cedars-Sinai

www.cedars-sinai.org

 
Since its beginning in 1902` Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation` continually setting new standards for quality and innovation in patient care` research` teaching and community service. Today` Cedars-Sinai is widely known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai receives consistent recognition for our excellence. Our awards include; being named one of America`s Best Hospitals by U.S. News & World Report` receiving the National Research Corporation`s Consumer Choice Award 19 years in a row for providing the highest-quality medical care in Los ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
George Carion
CTO and CISO Profile
Shaun Miller
Associate Chief Medical Information Officer Profile

Funding

Cedars-Sinai raised $20M on 12/11/2019

Similar Companies

Orahealth USA

Orahealth USA is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Signature MD

Through concierge medicine, SignatureMD creates doctor-patient partnerships that are based on extraordinary understanding and trust.

Science Oriented Solutions

Science Oriented Solutions is a Lawrenceville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CellASIC

CellASIC Corp. is a San Leandro, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.